Create issue ticket

1,462 Possible Causes for activity, glycine, reductase

  • Connective Tissue Disease

    […] intensity of the activity) by reducing the activity.[] Treatment: Aggressive treatment of intercurrent illness, carnitine, Protein, lysine, and tryptophan restriction Saccharopinuria (268700) α -Aminoadipic semialdehyde-glutamate reductase[] Scleroderma – an activation of immune cells that produces scar tissue in the skin, internal organs, and small blood vessels.[]

  • Influenza

    Seasonal influenza activity in the Southern Hemisphere was low overall, with influenza A(H1N1)pdm09 predominating in many regions.[] Immune-mediated necrotizing myopathy may be associated with myositis-specific autoantibodies including anti-single recognition particle and anti-3-hydroxy-3- methylglutaryl-coenzyme A reductase[] For example, the first row shows that the amino acid in position 5 of HA1 mutated from glycine (G, shown in light green) to valine (V, shown in burgundy) in November 1999,[]

  • Chenodeoxycholic Acid

    Patient 2 received a combined treatment with LDL-apheresis, CDCA and HMG-CoA reductase inhibitor.[] The activation of ERK1/2 was responsible for the activating phosphorylation of C/EBPβ.[] […] spectrometric (LC-ESI-MS/MS) method for the quantification of chenodeoxycholic acid (CDCA) and glycochenodeoxycholic acid (GCDCA), representative primary non-amidated and glycine-conjugated[]

  • Tuberculosis

    A review of their phenotypes indicated that two of these strains were negative for nitrate reductase.[] However, the role of IGRAs for the diagnosis of active tuberculosis (TB) remains unclear.[] Ramakrishnan L, Federspiel NA, Falkow S (2000) Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family.[]

  • Trimetrexate

    The most active quinazolines against both the P. carinii and the T. gondii enzyme were those with an ArCH2-NH or ArNHCH2 side chain.[] Abstract Drug Metabolism and Disposition November 1990, 18 (6) 980-986; Abstract The metabolic disposition of trimetrexate, a nonclassical inhibitor of dihydrofolate reductase[] Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA pre...[]

  • Dihydrofolate Reductase Deficiency

    Activity of the liver-cell homogenate from the other patient, which was one quarter of the normal level, was restored to only half normal activity by high cation concentration[] […] metabolism Glycine encephalopathy, also known as Non-ketotic hyperglycinaemia GABA related disorders GABA-transaminase-deficiency Succinate-semialdehyde-dehydroxylase deficiency[] Dihydrofolic acid reductase deficiency prevents the conversion of folic acid to tetrahydrofolic acid; the enzyme activity appears to differ in each patient.[]

  • Nonketotic Hyperglycinemia

    The activity of the T-protein was normal.[] .- ) Marfan's syndrome ( Q87.4 ) 5-alpha-reductase deficiency ( E29.1 ) Metabolic disorders E72 ICD-10-CM Diagnosis Code E72 Other disorders of amino-acid metabolism 2016[] […] hyperglycinemia Non-ketotic hyperglycinemia (disorder) nonketotic hyperglycinemia Glycine synthase deficiency Hyperglycinemia, Transient Neonatal GLYCINE ENCEPHALOPATHY GLYCINE[]

  • Disorder of Sulfur-Bearing Amino Acid Metabolism

    […] annotations that may be applicable to E72.10 : E00-E89 2019 ICD-10-CM Range E00-E89 Endocrine, nutritional and metabolic diseases Note All neoplasms, whether functionally active[] Synonym initial insensitive preferred GB English Dihydrofolate reductase deficiency Synonym initial insensitive acceptable GB English Deficiency of dihydrofolate reductase[] […] of glycine metabolism E72.8 Other specified disorders of amino-acid metabolism E72.81 Disorders of gamma aminobutyric acid metabolism E72.89 Other specified disorders of[]

  • Smith Lemli Opitz Syndrome

    Impaired DHCR7 function is associated with a spectrum of congenital malformations, intellectual impairment, epileptiform activity and autism spectrum disorder.[] Our data demonstrate that Smith-Lemli-Opitz syndrome is caused by mutations in the gene coding for 7-dehydrocholesterol reductase.[] The p.G366V is a novel mutation of the DHCR7 gene with guanine by thymine nucleotide exchange resulting in glycin by valin amino acid exchange in the dehydrocholesterol reductase[]

  • Fluvastatin

    Here, we explore whether this treatment could also increase telomerase activity.[] Product name Fluvastatin sodium salt, HMG-CoA reductase inhibitor Description Competitive HMG-CoA reductase inhibitor Biological description Competitive HMG-CoA reductase[] Abstract In this paper, we have investigated the mechanism of phototoxicity of fluvastatin, an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in human keratinocytes[]